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1. Introduction 
Acetylcholine decreases the level of cyclic AMP in 
thyroid slices stimulated by thyrgpstimulin. This 
effect described by us in pig tissue [l] has also been 
studied in dog and horse glands by Dumont and 
his collaborators [2,3] . Their results show that the 
cholinergic effect is due to the stimulation of a phos- 
phodiesterase activity which hydrolyses cyclic AMP 
[3] . As carbamylcholine stimulates the cyclic GMP 
accumulation in thyroid tissue [4] , a link between 
the two observations has been suggested. This 
hypothesis is supported by the fact that low concen- 
trations of cyclic GMP stimulate the hydrolysis of 
cyclic AMP by a crude cell free preparation of horse 
thyroid phosphodiesterase [ 51. 
The results reported here show that prostaglandin 
F,cw, which produces an elevation of cyclic GMP 
concentration in dog thyroid slices, does not repro- 
duce the carbamylcholine effect neither on the 
cyclic AMP level, nor on its in situ hydrolysis rate. 
2. Materials and methods 
Dog thyroid slices (about 100 mg) were routinely 
preincubated for 30 min at 37°C in 2 ml of Krebs- 
Ringer phosphate buffer (KRP) with glucose (1 mg/ 
ml). Then the slices were transferred into 2 ml of 
the same buffer containing theophylhn ( lob3 M) and 
various effecters according to the assays: TSH 
(15 mu/ml), carbamylcholine (1 Om5 M), PGFz (Y 
(10 Mg/ml). After incubation, the slices were trans- 
ferred into 1.5 ml perchloric acid (1 M) and homo- 
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genized. The cyclic nucleotides content was assayed 
by the radioimmunological method of Cailla et al. 
[6,7] , except that bound and free ligand were 
separated by filtration on Millipore filters (HAWP 
0.45 pm). To study the time course of CAMP disposal, 
we used incubation conditions similar to those 
described by Van Sande et al. [8] . Preincubated 
slices were incubated in the presence of TSH 25 mu/ml 
and theophyllin low3 M. After 15 min, trypsin was 
added (0.01% final concentration) and incubation 
was followed for 4 min. Then the slices were washed 
twice for 2 min in a medium containing a trypsin 
inhibitor. Finally they were incubated in fresh 
medium containing carbamylcholine or PGF2(w. At 
the end of the incubation, slices were dropped into 
perchloric acid and cyclic nucleotides assayed as 
described. 
The results are the means of duplicate determina- 
tions of separate experiments expressed with standard 
errors. 
3. Results 
In slices previously stimulated by TSH and theo- 
phyllin, we have studied the effect of carbamyl- 
choline and PGF*(w on cGMP accumulation and 
CAMP disposal. 
Figure 1 compares the time course of CYCfiC GMP 
level variations induced by carbamylcholine (a) and 
PGFza (b). The same maximal level is attained at 
2 min with the two stimulators, though a certain lag 
time is observed with PGF+. The elevation is tran- 
sient in both experiments, and the level returns to 
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Fig.1. Time course of cGMP variations in dog thyroid slices 
in which the CAMP level was previously elevated by TSH 
(25 mu/ml). (a), in the presence of carbamylcholine 
(lo-’ M); (b), in the presence of PGF,or (10 &g/ml M). 
basal after 15 min. In the absence of any stimulator, 
the basal evel of cyclic GMP remains constant during 
the period of incubation (not shown). 
Figure 2 shows the degradation rate of cyclic 
Ah4P which returns to basal level after removal of the 
TSH stimulation. As previously reported [3] , car- 
bamylcholine, increases the rate of hydrolysis, whereas 
PGF2a! is without effect. 
Figures 3 and 4 depict the result of experiments 
performed with the addition of 10m3 M theophylline 
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Fig.2. Time course of CAMP disposal in dog thyroid slices 
where its level was previously elevated by TSH (25 mu/ml). 
Effect of carbamylcholine (10e5 M) and PGF,a! (10 fig/ml). 
(o-o), none; (A-A), carbamylcholine; (e-e), PGF+ 
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Fig.3. Action of carbamylcholine (10e5 M) and/or PGF,or 
(10 pg/ml) on the cGMP accumulation in dog thyroid slices 
in the presence or absence of TSH (15 mu/ml). Theophyllin 
lo-’ M is present dueg the 1 S-min incubation. 
in order to decrease the degradation rate of cyclic 
nucleotides and to allow the comparison of the levels 
of cyclic AMP and cyclic GMP; these levels do not 
culminate at the same time when phosphodiesterase 
activities are not inhibited. After 15 min incubation 
with theophylline, we observe again the increased 
level of cyclic GMP in the presence of carbamyl- 
choline or PGF?(u. When present ogether, the two 
effecters do not produce additive ffects. As previously 
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Fig.4. Action of carbamylcholine (10e5 M) and/or PGF,u 
(10 pg/ml) on the stimulation by TSH (15 mu/ml) of the 
CAMP accumulation in dog thyroid slices. Theophyllin 
lo-” M is present during the 15-min incubation. 
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reported [2,4] , TSH is without effect on cyclic GMP 
levels. Slight decreases are observed when TSH is 
added to carbamylcholine and particularly to PGF,(r. 
However TSH is devoided of action when the two 
stimulators are present ogether. 
Cyclic AMP levels, which are not affected by 
carbamylcholine orPGF,(r alone or together, are 
stimulated five times by TSH. The TSH stimulation is 
partially antagonized (40%) by carbamylcholine and 
rather, enhanced by PGF2a. Moreover, PGFza does 
not modify the inhibitory effect of carbamylcholine. 
4. Discussion 
The decrease of the stimulated level of cyclic AMP, 
observed in dog thyroid tissue submitted to the 
simultaneous action of TSH and carbamylcholine, 
seems unequivocally consecutive to the increased 
degradation rate of the cyclic nucleotide [3 ] . It was 
tentatively proposed that cyclic GMP was the mediator 
of this cholinergic effect [5] , though its elevation by 
Mn2’ is not accompanied by a decrease of the cyclic 
AMP level [9] . The same absolute rise of cyclic GMP 
content with carbamylcholine and PGF2ar, joined to 
the absence of additivity, seems to be an indication 
of identical mode of action of the agonists on the 
same guanylate cyclase. Except for this similarity, 
other effects are completely different: PGF2a has no 
effect at all on the cyclic AMP level increased by 
TSH, nor on its degradation rate. 
Cyclic GMP alone is not directly responsible for 
the decrease of cyclic AMP level and free Ca2’ levels 
must be considered. 
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